USA - NASDAQ:CARE - US1461031064 - Common Stock
ChartMill assigns a Buy % Consensus number of 84% to CARE. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-02 | Hovde Group | Initiate | Outperform |
| 2024-08-29 | Raymond James | Maintains | Outperform -> Outperform |
| 2023-05-01 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2023-04-06 | Raymond James | Reiterate | Market Perform |
| 2022-12-05 | Piper Sandler | Reiterate | Neutral |
| 2022-10-06 | DA Davidson | Downgrade | Buy -> Neutral |
| 2022-07-07 | Raymond James | Upgrade | Market Perform -> Outperform |
| 2022-01-21 | Piper Sandler | Initiate | Neutral |
| 2021-07-08 | Raymond James | Downgrade | Outperform -> Market Perform |
| 2021-03-30 | DA Davidson | Upgrade | Neutral -> Buy |
9 analysts have analysed CARE and the average price target is 23.72 USD. This implies a price increase of 31.75% is expected in the next year compared to the current price of 17.9995.
The consensus rating for CARTER BANKSHARES INC (CARE) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.
The number of analysts covering CARTER BANKSHARES INC (CARE) is 9.